Artificial intelligence (AI) is revolutionizing health care, from diagnostics to patient care, but regulation is struggling to keep pace, according to a new paper from City St George's, University of ...
(RTTNews) - Novavax, Inc. (NVAX) Monday said the Food and Drug Administration or FDA has removed the clinical hold on its COVID-19-Influenza Combination (CIC) and stand-alone influenza vaccine ...
The Gaithersburg, Md., vaccine developer said Monday that the U.S. Food and Drug Administration had removed the clinical hold on its investigational new drug application for its combined vaccine and ...
Investing.com -- The U.S. Food and Drug Administration (FDA) has lifted its hold on a late-stage trial for Novavax’s ...
meeting with the U.S. Food and Drug Administration anticipated in the first half of 2025 Third Quarter 2024 Financial Results Cash and Cash Equivalents: Cash and cash equivalents as of September 30, ...
Rebouché said she’s also watching for another legal challenge to the abortion medication mifepristone, an Food and Drug Administration–approved drug used in a majority of abortions across the country.
Elon Musk's support for Trump could lead to significant policy shifts benefiting his companies. His potential role in the new ...
In one hand, a slender young woman holds up a bottle of clear liquid. The words “Skinny” and “GLP-1” — a new class of weight loss drugs — are visible on the label. In the other hand, she raises up a ...
Former host of the “Rush Limbaugh Show” James Golden, aka Bo Snerdley, discusses why he believes President-elect Donald Trump ...
Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...
The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in revolutionary technology.
Unicycive, which is seeking an FDA green light for oxylanthanum carbonate to treat hyperphosphatemia in patients with chronic kidney disease who are on dialysis, Monday said the agency set a target ...